Health

Taiwan Probes Possible Link Between Ozempic-Like Drugs and Blindness

Published
Updated

By TaiwanPlus

Open in App

Taiwanese health authorities are investigating a possible link between blindness and GLP-1 drugs, like the popular weight-loss drug Ozempic. A doctor in Taipei reported that a man suffered an “eye stroke” after injecting a GLP-1 class drug for 10 months. The patient reportedly went completely blind in one eye and lost almost all vision in the other. The case comes as the US Food and Drug Administration has recently warned of a similar potential complication. In Taiwan, GLP-1 drugs are currently approved only for the treatment of type 2 diabetes, not for weight loss. According to Taiwan's health authorities, the nation has received 314 reports of suspected adverse reactions linked to the drugs so far, including 12 cases involving eye disorders. 

Can GLP-1 Drugs Cause Blindness?

==  
REPORTER:  
Taiwanese health authorities are investigating a possible link between blindness and drugs like Ozempic, commonly used for weight loss and diabetes.

A Taipei doctor reported that a man suffered an “eye stroke” after injecting a GLP-1 class drug for ten months. The patient went completely blind in one eye and lost almost all vision in the other. The US FDA has also recently warned of a similar complication. In Taiwan, these drugs are only approved to treat Type 2 diabetes. So far, Taiwan has reported 314 cases of suspected adverse reactions to the drugs, including 12 cases involving eye disorders.
[==SOT]##

---
Title: GLP-1 Eye Stroke Case in Taiwan

==  
REPORTER:  
Taiwanese authorities are investigating a first drug injury case linked to a drug widely known for weight loss.

The case in Taiwan was reported just days after the US Food and Drug Administration warned that GLP-1 agonists could increase the risk of eye stroke, a rare but serious adverse event. The patient, who was using Ozempic for weight loss, experienced an eye stroke that seriously affected vision in one eye. In Taiwan, Ozempic is only approved to treat Type 2 diabetes.
[==SOT]##